Lataa...
A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth
Prolactin secreting pituitary adenomas (prolactinomas) is the most common pituitary tumors in humans. Animal studies have identified aggressive prolactinoma development in fetal alcohol exposed rats. We have recently identified a combination treatment of a μ opioid receptor antagonist naltrexone and...
Tallennettuna:
| Julkaisussa: | J Cell Commun Signal |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559393/ https://ncbi.nlm.nih.gov/pubmed/28144772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-017-0374-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|